Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04180241
Other study ID # 2017/1630-31
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date December 31, 2027

Study information

Verified date May 2024
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Per Oral Endoscopic Myotomy (POEM); comparison of two surgical techniques division all the esophageal muscle layers versus division the inner circular muscle layer of the esophagus only.


Description:

Prior to surgery, all patients undergo upper endoscopy , x-ray "time barium" manometry, 24 hours pH registration. Moreover Quality of Life instrument (RAND-36), GSRS (Gastrointestinal Symptom Rating Scale) and a dysphagia score (Eckardt score) are completed by all patients. Follow-up with surveys 3, 6, 12, and 36 months (GSRS, RAND-36 and Eckardt score). At 3,12 and 36 months an x-ray "time barium" is performed and after 12 months a gastroscopy and at 24 hours esophageal pH monitoring are performed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 55
Est. completion date December 31, 2027
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Newly diagnosed achalasia - the patient should understand the nature and the purpose of the study and give informed consent Exclusion Criteria: - previous surgical treatment of achalasia - inability to understand the contents of or follow the protocol - other pathology as an explanation for the obstruction of the esophageal transition

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
POEM
Peroral endoscopic myotomy

Locations

Country Name City State
Sweden Karolinska Institutet Stockholm Stockholm County Council
Sweden Karolinska Institutet, Ersta Hospital Stockholm Region Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary The proportion of patients who develop gastroesophageal reflux disease (GERD) Measured as esophageal acid exposure (pH <4) > 4% of recorded time 1 year
Secondary Esophageal emptying function Measured by Time Barium Swallow X-ray 1 year
Secondary Eckardt score The Eckardt score consists of 4 components including dysphagia, chest pain, regurgitation, and weight loss.Each component is assigned a score from 0 to 3 based on the patient's self-reported response, resulting in a total score that can vary from 0 to 12, higher scores mean a worse outcome. 1 year
Secondary RAND-36 The RAND-36 It is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Physical and mental health summary scores are also derived from the eight RAND-36 scales. higher scores mean a better outcome. 1 year
Secondary Dysmotility measured by Manometry 1 year
Secondary Gastrointestinal Symptom Rating Scale (GSRS) Scoring;The questionnaire, which contains 15 items, uses a seven-graded Likert scale, where 1 represents the most positive option and 7 the most negative one.
A mean value for the items in each dimension should be calculated:
Diarrhoea syndrome: 11. Increased passage of stools 12. Loose stools 14. Urgent need for defecation Indigestion syndrome: 6. Borborygmus 7. Abdominal distension 8. Eructation 9. Increased flatus Constipation syndrome: 10. Decreased passage of stools 13. Hard stools 15. Feeling of incomplete evacuation Abdominal pain syndrome: 1. Abdominal pain 4. Sucking sensations 5. Nausea and vomiting Reflux syndrome: 2. Heartburn 3. Acid regurgitation
1 year
See also
  Status Clinical Trial Phase
Completed NCT01399476 - Endoscopic Myotomy of the Lower Esophageal Sphincter for Achalasia N/A
Recruiting NCT05326113 - The Effect of Physiotherapy on Post POEM Reflux N/A
Recruiting NCT06044155 - redoPOEM : Failure of a First POEM
Recruiting NCT02989883 - Clinical Outcomes of Peroral Endoscopic Myotomy N/A
Terminated NCT02606578 - Achalasia Patient Reported Outcomes
Recruiting NCT01793922 - POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM) N/A
Recruiting NCT01302288 - Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia Phase 2
Terminated NCT03875365 - Institutional Outcome Data From Per-oral Plication of the Esophagus
Enrolling by invitation NCT02770859 - Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository
Recruiting NCT05905016 - Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
Completed NCT01692106 - A Clinical Study of Per Oral Endoscopic Myotomy (POEM) in Patients Suffering From Achalasia N/A
Completed NCT01405469 - Endoscopic Peroral Myotomy for Treatment of Achalasia N/A
Completed NCT01402518 - Per-Oral Endoscopic Myotomy
Not yet recruiting NCT00790465 - Efficacy of Dark Chocolate in Achalasia Patients Phase 1/Phase 2
Recruiting NCT01799967 - Minimally Invasive Surgery of the Gastro-esophageal Junction
Terminated NCT00604942 - vMII for Measurement of Oesophageal Bolus Transport and Reflux N/A
Recruiting NCT06405412 - Effects of Malnutrition on Respiratory and Renal Functions in Patients Undergoing Peroral Endoscopic Myotomy (POEM) N/A
Not yet recruiting NCT06042127 - POEM-F for Achalasia International Study N/A
Completed NCT04752670 - ConMed Beamer Study
Completed NCT02314741 - Peroral Endoscopic Myotomy (POEM) for Esophageal Motility N/A